{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:36:32Z","timestamp":1794281792808,"version":"4.9.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00415-025-13103-2","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T12:00:26Z","timestamp":1746446426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Core diagnostic features of stiff person syndrome: insights from a case-control study"],"prefix":"10.1007","volume":"272","author":[{"given":"Shuvro","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5284-4681","authenticated-orcid":false,"given":"Scott D.","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"10","key":"13103_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/wnl.55.10.1531","volume":"55","author":"MC Dalakas","year":"2000","unstructured":"Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55(10):1531\u20131535. https:\/\/doi.org\/10.1212\/wnl.55.10.1531","journal-title":"Neurology"},{"issue":"2","key":"13103_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/archneurol.2011.991","volume":"69","author":"A McKeon","year":"2012","unstructured":"McKeon A et al (2012) Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol 69(2):230\u2013238. https:\/\/doi.org\/10.1001\/archneurol.2011.991","journal-title":"Arch Neurol"},{"issue":"6","key":"13103_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","volume":"92","author":"A Budhram","year":"2021","unstructured":"Budhram A et al (2021) Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry 92(6):645\u2013654. https:\/\/doi.org\/10.1136\/jnnp-2020-325275","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"13103_CR4","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1084\/jem.178.6.2219","volume":"178","author":"P De Camilli","year":"1993","unstructured":"De Camilli P et al (1993) The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med 178(6):2219\u20132223. https:\/\/doi.org\/10.1084\/jem.178.6.2219","journal-title":"J Exp Med"},{"issue":"1","key":"13103_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","volume":"70","author":"A McKeon","year":"2013","unstructured":"McKeon A et al (2013) Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 70(1):44\u201350. https:\/\/doi.org\/10.1001\/jamaneurol.2013.574","journal-title":"JAMA Neurol"},{"issue":"2","key":"13103_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","volume":"11","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC (2009) Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol 11(2):102\u2013110. https:\/\/doi.org\/10.1007\/s11940-009-0013-9","journal-title":"Curr Treat Options Neurol"},{"key":"13103_CR7","doi-asserted-by":"publisher","first-page":"577915","DOI":"10.1016\/j.jneuroim.2022.577915","volume":"369","author":"SD Newsome","year":"2022","unstructured":"Newsome SD, Johnson T (2022) Stiff person syndrome spectrum disorders; more than meets the eye. J Neuroimmunol 369:577915. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577915","journal-title":"J Neuroimmunol"},{"issue":"1","key":"13103_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-018-1232-z","volume":"19","author":"G Rakocevic","year":"2019","unstructured":"Rakocevic G, Alexopoulos H, Dalakas MC (2019) Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder. BMC Neurol 19(1):1. https:\/\/doi.org\/10.1186\/s12883-018-1232-z","journal-title":"BMC Neurol"},{"key":"13103_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12123-0","author":"Y Wang","year":"2023","unstructured":"Wang Y et al (2023) Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disorders. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-12123-0","journal-title":"J Neurol"},{"issue":"3","key":"13103_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s13311-022-01188-w","volume":"19","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC (2022) Stiff-person syndrome and GAD Antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies. Neurotherapeutics 19(3):832\u2013847. https:\/\/doi.org\/10.1007\/s13311-022-01188-w","journal-title":"Neurotherapeutics"},{"issue":"13","key":"13103_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJM198509263131306","volume":"313","author":"JH Wasson","year":"1985","unstructured":"Wasson JH, Sox HC, Neff RK, Goldman L (1985) Clinical prediction rules. applications and methodological standards. N Engl J Med 313(13):793\u2013799. https:\/\/doi.org\/10.1056\/NEJM198509263131306","journal-title":"N Engl J Med"},{"issue":"24","key":"13103_CR12","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","volume":"71","author":"BB Murinson","year":"2008","unstructured":"Murinson BB, Guarnaccia JB (2008) Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 71(24):1955\u20131958. https:\/\/doi.org\/10.1212\/01.wnl.0000327342.58936.e0","journal-title":"Neurology"},{"issue":"Pt 10","key":"13103_CR13","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131(Pt 10):2553\u20132563. https:\/\/doi.org\/10.1093\/brain\/awn183","journal-title":"Brain"},{"issue":"6","key":"13103_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","volume":"73","author":"E Martinez-Hernandez","year":"2016","unstructured":"Martinez-Hernandez E et al (2016) Clinical and Immunologic Investigations in patients with stiff-person spectrum disorder. JAMA Neurol 73(6):714\u2013720. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0133","journal-title":"JAMA Neurol"},{"issue":"7","key":"13103_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/acn3.51791","volume":"10","author":"NH Chia","year":"2023","unstructured":"Chia NH et al (2023) Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. Ann Clin Transl Neurol 10(7):1083\u20131094. https:\/\/doi.org\/10.1002\/acn3.51791","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"13103_CR16","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1212\/NXI.0000000000000696","volume":"7","author":"A Mu\u00f1oz-Lopetegi","year":"2020","unstructured":"Mu\u00f1oz-Lopetegi A et al (2020) Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm 7(3):e696. https:\/\/doi.org\/10.1212\/NXI.0000000000000696","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"13103_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ et al (2006) Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81(9):1207\u20131214. https:\/\/doi.org\/10.4065\/81.9.1207","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"13103_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13311-019-00796-3","volume":"17","author":"MM Dimitriadou","year":"2020","unstructured":"Dimitriadou MM, Alexopoulos H, Akrivou S, Gola E, Dalakas MC (2020) Anti-neuronal antibodies within the IVIg preparations: importance in clinical practice. Neurotherapeutics 17(1):235\u2013242. https:\/\/doi.org\/10.1007\/s13311-019-00796-3","journal-title":"Neurotherapeutics"},{"issue":"7","key":"13103_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/s0025-6196(12)65157-x","volume":"65","author":"C Armon","year":"1990","unstructured":"Armon C, McEvoy KM, Westmoreland BF, McManis PG (1990) Clinical neurophysiologic studies in stiff-man syndrome: use of simultaneous video-electroencephalographic-surface electromyographic recording. Mayo Clin Proc 65(7):960\u2013967. https:\/\/doi.org\/10.1016\/s0025-6196(12)65157-x","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"13103_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/CND.0000000000000302","volume":"22","author":"Y Li","year":"2020","unstructured":"Li Y, Thakore N (2020) An appraisal of electrodiagnostic studies in stiff person syndrome. J Clin Neuromuscul Dis 22(2):84\u201389. https:\/\/doi.org\/10.1097\/CND.0000000000000302","journal-title":"J Clin Neuromuscul Dis"},{"issue":"9","key":"13103_CR21","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/biomedicines11092500","volume":"11","author":"B Vlad","year":"2023","unstructured":"Vlad B, Wang Y, Newsome SD, Balint B (2023) Stiff person spectrum disorders-an update and outlook on clinical, pathophysiological and treatment perspectives. Biomedicines 11(9):2500. https:\/\/doi.org\/10.3390\/biomedicines11092500","journal-title":"Biomedicines"},{"issue":"20","key":"13103_CR22","doi-asserted-by":"publisher","first-page":"e2126","DOI":"10.1212\/WNL.0000000000008943","volume":"94","author":"J Lambe","year":"2020","unstructured":"Lambe J, Rothman A, Prince J, Saidha S, Calabresi PA, Newsome SD (2020) Retinal pathology occurs in stiff-person syndrome. Neurology 94(20):e2126\u2013e2131. https:\/\/doi.org\/10.1212\/WNL.0000000000008943","journal-title":"Neurology"},{"key":"13103_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1273256","author":"J Koshorek","year":"2023","unstructured":"Koshorek J et al (2023) The many faces of gastrointestinal dysfunction in stiff person syndrome spectrum disorders. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1273256","journal-title":"Front Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13103-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:42:10Z","timestamp":1747658530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13103-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["13103"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13103-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.D. Newsome received consultancy fees for scientific advisory boards from Biogen, Genentech, Inc., Bristol Myers Squibb, Novartis, and TG Therapeutics; study lead PI for a Roche clinical trial program; received research funding (paid directly to institution) from Biogen, Lundbeck, Roche, Genentech, Inc., Sanofi, National MS Society, The Stiff Person Syndrome Research Foundation, Department of Defense, and Patient-Centered Outcomes Research Institute. Y. Wang received consultancy fees from TG Therapeutics; received research funding (paid directly to institution) from Genentech, uniQure, and the National Institutes of Health. S. Roy has nothing to disclose. Y. Huang has nothing to disclose. C. Hu has nothing to disclose. KC. Fitzgerald has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Johns Hopkins University Institutional Review Board (IRB00154798) as part of an ongoing longitudinal observational study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Chart reviews and participant consent followed the IRB-approved protocol.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"377"}}